Vip Viprakasit

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

Addressing Obstetric and Gynecologic Needs in Thalassemia.

Addressing Obstetric and Gynecologic Needs in Thalassemia.

Journal: O&G open

Published: January 08, 2026

Detection of Liver Iron Overload in Patients With Thalassemia With Ultra-short Echo Time MR Imaging on 3.0T.

Detection of Liver Iron Overload in Patients With Thalassemia With Ultra-short Echo Time MR Imaging on 3.0T.

Journal: Investigative radiology

Published: September 06, 2025

Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources.

Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources.

Journal: The Lancet. Haematology

Published: August 24, 2025

Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential.

Thailand's Emerging Role in the Cell and Gene Therapy Revolution: A Review of Progress and Potential.

Journal: Clinical and translational science

Published: August 24, 2025

Induced pluripotent stem cell-based modeling of hemolytic anemia in patients with compound heterozygous KLF1 mutations reveals defective erythroid differentiation.

Induced pluripotent stem cell-based modeling of hemolytic anemia in patients with compound heterozygous KLF1 mutations reveals defective erythroid differentiation.

Journal: Stem cell research & therapy

Published: August 08, 2025

Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion-Dependent Thalassemia Identified Using Whole-Genome Sequencing.

Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion-Dependent Thalassemia Identified Using Whole-Genome Sequencing.

Journal: Clinical and translational science

Published: July 02, 2025

Bridging Pharmacokinetics and Pharmacodynamics: A PBPK/PD Model-Based Approach for Deferasirox Dosing in Transfusion-Dependent Thalassemia.

Bridging Pharmacokinetics and Pharmacodynamics: A PBPK/PD Model-Based Approach for Deferasirox Dosing in Transfusion-Dependent Thalassemia.

Journal: Clinical and translational science

Published: June 04, 2025

Luspatercept versus mitapivat for non-transfusion-dependent β-thalassemia: Dare to compare?

Luspatercept versus mitapivat for non-transfusion-dependent β-thalassemia: Dare to compare?

Journal: HemaSphere

Published: April 26, 2025

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study.

Journal: Orphanet journal of rare diseases

Published: April 03, 2025

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.

Efficacy and safety of luspatercept in non-transfusion-dependent β-thalassemia: long-term results from the BEYOND study.

Journal: Blood advances

Published: March 18, 2025

Bioanalytical method for NAD+ detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection.

Bioanalytical method for NAD+ detection in blood plasma utilizing solution-phase Candida boidinii formate dehydrogenase and electrochemical detection.

Journal: The Analyst

Published: January 29, 2025

Non-Transfusion-Dependent Thalassemia: An Image Gallery Worth a Thousand Words.

Non-Transfusion-Dependent Thalassemia: An Image Gallery Worth a Thousand Words.

Journal: American journal of hematology

Published: January 10, 2025

Showing 1-12 of 123

Last Updated: 09/26/2026